ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 1 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,994,204 | -33.2% | 99,412 | -6.1% | 0.00% | -33.3% |
| Q2 2023 | $2,986,676 | +215.3% | 105,873 | +92.3% | 0.01% | +200.0% |
| Q1 2023 | $947,202 | -35.9% | 55,070 | -24.9% | 0.00% | -33.3% |
| Q4 2022 | $1,477,288 | -14.4% | 73,351 | -8.0% | 0.00% | -25.0% |
| Q3 2022 | $1,726,000 | -21.0% | 79,766 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $2,184,000 | -19.2% | 77,788 | +32.7% | 0.00% | -20.0% |
| Q1 2022 | $2,703,000 | -45.7% | 58,619 | -1.1% | 0.01% | -37.5% |
| Q4 2021 | $4,980,000 | +30.0% | 59,264 | +3.0% | 0.01% | +33.3% |
| Q3 2021 | $3,831,000 | +54.9% | 57,513 | +23.6% | 0.01% | +50.0% |
| Q2 2021 | $2,474,000 | +144.7% | 46,523 | +99.4% | 0.00% | +100.0% |
| Q1 2021 | $1,011,000 | -16.6% | 23,336 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,212,000 | – | 23,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |